Publication | Closed Access

Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis

Antiparasitic AgentLeishmania InfantumMedicineParasitic ProtozoaImmunologySelective Antileishmanial ActivityImmunotherapyPharmacologyVisceral LeishmaniasisParasitologyDrug Discovery